应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FENC Fennec Pharmaceuticals Inc.
未开盘 05-17 16:00:00 EDT
7.04
-0.08
-1.12%
盘后
7.04
+0.00
0.00%
17:52 EDT
最高
7.09
最低
6.70
成交量
30.67万
今开
7.03
昨收
7.12
日振幅
5.48%
总市值
1.92亿
流通市值
1.08亿
总股本
2,732万
成交额
211.21万
换手率
1.99%
流通股本
1,538万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
HC Wainwright & Co.:维持Fennec Pharmaceuticals(FENC.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。
智通财经 · 05-15
HC Wainwright & Co.:维持Fennec Pharmaceuticals(FENC.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。
Fennec Pharmaceuticals Inc.盘中异动 股价大跌5.07%报9.74美元
自选股智能写手 · 04-18
Fennec Pharmaceuticals Inc.盘中异动 股价大跌5.07%报9.74美元
Fennec Pharmaceuticals Inc.2023财年实现净利润-16.05百万美元,同比增加32.31%
自选股智能写手 · 03-22
Fennec Pharmaceuticals Inc.2023财年实现净利润-16.05百万美元,同比增加32.31%
Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨6.87%
自选股智能写手 · 02-29
Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨6.87%
Fennec Pharmaceuticals Inc盘中异动 股价大涨6.28%
自选股智能写手 · 02-14
Fennec Pharmaceuticals Inc盘中异动 股价大涨6.28%
Fennec Pharmaceuticals Inc盘中异动 急速跳水5.06%
自选股智能写手 · 02-14
Fennec Pharmaceuticals Inc盘中异动 急速跳水5.06%
Fennec Pharmaceuticals Inc盘中异动 快速下跌5.85%报9.81美元
自选股智能写手 · 01-26
Fennec Pharmaceuticals Inc盘中异动 快速下跌5.85%报9.81美元
Fennec Pharmaceuticals Inc盘中异动 急速上涨5.05%报9.99美元
自选股智能写手 · 2023-12-15
Fennec Pharmaceuticals Inc盘中异动 急速上涨5.05%报9.99美元
加载更多
公司概况
公司名称:
Fennec Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的,其名称是“粘着”技术公司,随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司,以及加拿大的一家加拿大公司(简称“CBI”),在这里被统称为“公司”,是一家生物制药公司,有一个正在开发中的产品,用于治疗癌症。该公司是一家生物制药公司,主要关注硫代硫酸钠(“STS”)的开发,以预防小儿癌症患者体内铂中毒的毒性。
发行价格:
--
{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":7.04,"timestamp":1715976000000,"preClose":7.12,"halted":0,"volume":306739,"hourTrading":{"tag":"盘后","latestPrice":7.04,"preClose":7.04,"latestTime":"17:52 EDT","volume":1137,"amount":7989.4796,"timestamp":1715982773206},"delay":0,"floatShares":15376594,"shares":27322141,"eps":0.105081,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.08,"latestTime":"05-17 16:00:00 EDT","open":7.03,"high":7.09,"low":6.7,"amount":2112102.4258696,"amplitude":0.054775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.105081,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"adjPreClose":7.12,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.05,"preClose":7.12,"latestTime":"09:29 EDT","volume":2108,"amount":14383.1614128,"timestamp":1715952599999},"postHourTrading":{"tag":"盘后","latestPrice":7.04,"preClose":7.04,"latestTime":"17:52 EDT","volume":1137,"amount":7989.4796,"timestamp":1715982773206},"volumeRatio":0.6191732192660336},"requestUrl":"/m/hq/s/FENC/","defaultTab":"news","newsList":[{"id":"2435636492","title":"HC Wainwright & Co.:维持Fennec Pharmaceuticals(FENC.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435636492","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435636492?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:16","pubTimestamp":1715771795,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Fennec Pharmaceuticals(FENC.US)评级,由买入调整至买入评级, 目标价由18.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151916378b0b1f18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428373010","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大跌5.07%报9.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428373010","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428373010?lang=zh_cn&edition=full","pubTime":"2024-04-18 03:54","pubTimestamp":1713383670,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日03时54分,Fennec Pharmaceuticals Inc.股票出现波动,股价快速下跌5.07%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Fennec Pharmaceuticals Inc.公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。消息层面,截至03时54分,《Form 144 | Fennec Pharmaceuticals高管拟出售2.22万股股份,价值约22.88万美元》资讯为影响Fennec Pharmaceuticals Inc.的重要信息。该信息摘要如下:根据美国证券交易委员会美东时间4月15日披露的文件,$Fennec Pharmaceuticals $高管ADRIAN J HAIGH拟于4月15日出售2.22万股普通股股份,总市值约22.88万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180354307921482f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421830006","title":"Fennec Pharmaceuticals Inc.2023财年实现净利润-16.05百万美元,同比增加32.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421830006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421830006?lang=zh_cn&edition=full","pubTime":"2024-03-22 06:18","pubTimestamp":1711059495,"startTime":"0","endTime":"0","summary":"12月31日,Fennec Pharmaceuticals Inc.公布财报,公告显示公司2023财年净利润为-16.05百万美元,同比增加32.31%;其中营业收入为21.25百万美元,同比增加1279.87%,每股基本收益为-0.60美元。机构评级:截至2023年12月31日,当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测,其中目标均价为16.50美元,其中最低目标价为16.00美元,最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403220618178b528895&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415052618","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415052618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415052618?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:44","pubTimestamp":1709217865,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时44分,Fennec Pharmaceuticals Inc.股票出现异动,股价快速拉升6.87%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.04%。其相关个股中,Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃,换手率分别为2057.91%、114.77%、54.18%,振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为81.15%、51.74%、34.76%。Fennec Pharmaceuticals Inc.公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292244267915f927&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411656302","title":"Fennec Pharmaceuticals Inc盘中异动 股价大涨6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411656302","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411656302?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:33","pubTimestamp":1707921183,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时33分,Fennec Pharmaceuticals Inc股票出现异动,股价急速拉升6.28%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Engene Holdings Inc、Engene Holdings Inc C/Wts 31/10/2028 Cl A、Cogent Biosciences Inc涨幅较大,Azitra Inc、Kintara Therapeutics Inc、Fresh2 Group Limited较为活跃,换手率分别为15.48%、14.98%、11.48%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Fresh2 Group Limited、Cogent Biosciences Inc,振幅分别为20.43%、12.69%、12.45%。Fennec Pharmaceuticals Inc公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142233047a43a503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142233047a43a503&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411605163","title":"Fennec Pharmaceuticals Inc盘中异动 急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411605163","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411605163?lang=zh_cn&edition=full","pubTime":"2024-02-14 01:42","pubTimestamp":1707846126,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日01时42分,Fennec Pharmaceuticals Inc股票出现波动,股价急速下跌5.06%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.64%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm Plc C/Wts 10/02/2028 、Zura Bio Limited C/Wts 20/03/2028 涨幅较大,Biodexa Pharmaceuticals Plc、Revelation Biosciences Inc、Adial Pharmaceuticals Inc较为活跃,换手率分别为422.44%、207.89%、128.22%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Renovaro Biosciences Inc、Calidi Biotherapeutics Inc,振幅分别为53.85%、51.26%、50.00%。Fennec Pharmaceuticals Inc公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401420779114135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401420779114135&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406957097","title":"Fennec Pharmaceuticals Inc盘中异动 快速下跌5.85%报9.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406957097","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406957097?lang=zh_cn&edition=full","pubTime":"2024-01-26 22:32","pubTimestamp":1706279533,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日22时32分,Fennec Pharmaceuticals Inc股票出现波动,股价大幅下跌5.85%。截至发稿,该股报9.81美元/股,成交量2.2922万股,换手率0.09%,振幅0.94%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Corbus Pharmaceuticals Holdings In、Panbela Therapeutics Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大,Panbela Therapeutics Inc、Tc Biopharm Plc、Processa Pharmaceuticals Inc较为活跃,换手率分别为1050.79%、911.93%、447.53%,振幅较大的相关个股有Corbus Pharmaceuticals Holdings In、Dermata Therapeutics Inc、Cns Pharmaceuticals Inc,振幅分别为29.03%、17.75%、14.89%。Fennec Pharmaceuticals Inc公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622321381e6c58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622321381e6c58d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391685764","title":"Fennec Pharmaceuticals Inc盘中异动 急速上涨5.05%报9.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2391685764","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391685764?lang=zh_cn&edition=full","pubTime":"2023-12-15 04:55","pubTimestamp":1702587311,"startTime":"0","endTime":"0","summary":"北京时间2023年12月15日04时55分,Fennec Pharmaceuticals Inc股票出现异动,股价快速拉升5.05%。Fennec Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Aileron Therapeutics Inc、Dermata Therapeutics Inc C/Wts 13/08/2026 涨幅较大,C4 Therapeutics Inc、Zyversa Therapeutics Inc、Aditxt Inc较为活跃,换手率分别为323.50%、182.04%、122.69%,振幅较大的相关个股有Aileron Therapeutics Inc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为101.60%、90.47%、84.17%。Fennec Pharmaceuticals Inc公司简介:Fennec Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231215045511861c5147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231215045511861c5147&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":-0.2779},{"period":"1month","weight":-0.2742},{"period":"3month","weight":-0.2186},{"period":"6month","weight":-0.1538},{"period":"1year","weight":-0.0512},{"period":"ytd","weight":-0.3725}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的,其名称是“粘着”技术公司,随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司,以及加拿大的一家加拿大公司(简称“CBI”),在这里被统称为“公司”,是一家生物制药公司,有一个正在开发中的产品,用于治疗癌症。该公司是一家生物制药公司,主要关注硫代硫酸钠(“STS”)的开发,以预防小儿癌症患者体内铂中毒的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.027108},{"month":6,"riseRate":0.5,"avgChangeRate":0.038502},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026967},{"month":8,"riseRate":0.5,"avgChangeRate":-0.036198},{"month":9,"riseRate":0.666667,"avgChangeRate":0.058778},{"month":10,"riseRate":0.428571,"avgChangeRate":0.012399},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.002651},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}